Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for potential thrombogenicity of prothrombin complex concentrates.

T J Snape

    Developments in Biological Standardization
    |January 1, 1979
    PubMed
    Summary

    This study evaluates laboratory methods for assessing thrombogenicity in prothrombin complex concentrates. Improvements in fractionation procedures enhance concentrate performance in these crucial safety tests.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pteridine reductase (PTR1): initial structure-activity relationships studies of potential leishmanicidal arylindole derivatives compounds.

    SAR and QSAR in environmental research·2023
    Same author

    2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity.

    Current medicinal chemistry·2012
    Same author

    Versatility of a new bioinorganic catalyst: palladized cells of Desulfovibrio desulfuricans and application to dehalogenation of flame retardant materials.

    Environmental technology·2009
    Same author

    Quality control in the development of coagulation factor concentrates.

    Developments in biological standardization·1987
    Same author

    Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.

    British journal of haematology·1982
    Same author

    Evaluation of an AutoAnalyzer method for quantitating anti-A and anti-B haemagglutinins in factor VIII preparations.

    Journal of clinical pathology·1980

    Area of Science:

    • Biochemistry
    • Hematology
    • Medical Technology

    Background:

    • Prothrombin complex concentrates (PCCs) are critical for treating coagulation factor deficiencies.
    • Assessing the thrombogenicity of PCCs is essential for patient safety.
    • Existing laboratory methods for thrombogenicity testing require critical evaluation.

    Purpose of the Study:

    • To describe and critically compare laboratory methods for testing PCC thrombogenicity.
    • To discuss alternative methods for presenting test results.
    • To examine how changes in fractionation procedures impact PCC performance.

    Main Methods:

    • Detailed description of the author's laboratory testing protocols for PCC thrombogenicity.
    • Comparative analysis of different thrombogenicity assay methodologies.
    • Evaluation of result presentation formats for clarity and utility.

    Main Results:

    • Identification of strengths and limitations across various thrombogenicity testing methods.
    • Discussion of how data visualization influences the interpretation of PCC safety.
    • Correlation between specific fractionation modifications and improved PCC performance in assays.

    Conclusions:

    • Standardized and validated methods are crucial for reliable thrombogenicity assessment of PCCs.
    • Optimized fractionation procedures can significantly reduce the thrombogenic potential of PCCs.
    • Further research into novel testing and result reporting is warranted to ensure PCC safety.

    Related Experiment Videos